Dr. Pietro Alessandro Ambrogio Canetta, MD

Dr. Canetta practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Canetta's NPI, 1003015439, was assigned on July 16, 2007. Dr. Canetta graduated from Vagelos College of Physicians and Surgeons in 2005. Dr. Canetta holds New York license 244282.

Dr. Canetta's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Canetta's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Canetta is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Canetta to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Canetta practices. Vendor and product names are available with a free account.

Nephrology is Dr. Canetta's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Canetta is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Canetta's licenses on file in 4 states: New York, Florida, New Jersey and Connecticut.

Dmand AI lists acute kidney failure, chronic kidney disease, gout and kidney disease among the conditions Dr. Canetta treats.

CMS data shows 842 Medicare services from Dr. Canetta across 9 procedure codes in 2024, for 261 Medicare patients. Medicare paid $89,174 for them.

CMS counts 261 Medicare patients who saw Dr. Canetta in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 5.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Canetta's median patient age at 54, with 47% women.

In 2024, Dr. Canetta wrote 357 Medicare Part D claims for 65 patients. 81% of them were for generic drugs. CMS names the drug for 160 of them, across 9 drugs with 11 or more claims each, at $41,757 in total drug cost. In 2023, CMS named 260 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Canetta for performance year 2024, reported through an alternative payment model (APM). Dr. Canetta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Canetta as offering telehealth.

Dmand AI links 63 papers to Dr. Canetta, published from 2012 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Biopsy, Proteinuria and Glomerulonephritis, Membranous. Dr. Canetta has published most often in Clin J Am Soc Nephrol. Dr. Canetta's most frequent co-authors are Andrew S. Bomback, MD, Gerald Bernard Appel, MD and Jai Radhakrishnan, MD.

Dmand AI links Dr. Canetta to 3 clinical trials, 2 of them phase 4 studies. Conditions studied include Glomerulonephritis, IGA, Glomerulonephritis, Membranous and Glomerulonephritis. Mayo Clinic sponsors the most, 2.

CMS Open Payments shows 38 general payments to Dr. Canetta from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 93% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $16,147. It also lists 3 research payments totaling $7,034 from 2024 to 2025.

Dmand AI lists 1 award for Dr. Canetta, most recently CMS Stage 1 2012 in 2012.

Dr. Canetta graduated from Vagelos College of Physicians and Surgeons in 2005.

Dr. Canetta is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.